Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Lupin Ltd.
NSE: LUPIN
|
BSE: 500257
|
ISIN: INE326A01037
|
Industry: Pharmaceuticals
US FDA Observation
|
Mid-range Performer
1979.7000
22.40
(
1.14
%)
NSE
Sep 10, 2025
15:48 PM
Volume:
849.6K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Lupin Ltd.
11 Mar 2021
US FDA Observation
1979.70
1.14%
According to total sales audit data from IMS, Indian Pharma Market (IPM) grew 2.6% YoY in...
Buy:
Lupin Ltd.
by
Emkay
Target: 1130
Recommendation
Target
Emkay
Number of FII/FPI investors increased from 979 to 987 in Jun 2025 qtr.
More from Lupin Ltd.
Recommended
Market closes higher, IDBI Bank files an insolvency case against Zee Entertainment
Trendlyne Marketwatch |
10 Sep 2025, 04:02PM
Five stocks to buy from analysts this week - September 9, 2025
The Baseline |
09 Sep 2025, 05:38PM
Lupin expects normalization by September quarter
|
17 Apr 2020